GGrantIndex
Sort

46,585 grants matching heart failure

Tuning and Tagging the O-GlcNAc Modification

$445,400
Natasha Elizabeth Zachara · Johns Hopkins University · U01 · FY2018 · CA

Tuning and Tagging the O-GlcNAc Modification

$445,400
Natasha Elizabeth Zachara · Johns Hopkins University · U01 · FY2019 · CA

Tuning and Tagging the O-GlcNAc Modification

$445,400
Natasha Elizabeth Zachara · Johns Hopkins University · U01 · FY2020 · CA

Cardiac Functional and Structural Implications of Lamin A/C Mutations

$445,371
Anna Grosberg · University Of California-Irvine · R01 · FY2019 · HL

Phenotypic Assay Design and Development for Rare and Neglected Diseases

$445,362
James Inglese · National Center For Advancing Translational Sciences · ZIA · FY2019 · TR

Nitroso/redox balance in myocardial infarction

$445,322
Joshua M Hare · University Of Miami School Of Medicine · R01 · FY2012 · HL

Nitroso/redox balance in myocardial infarction

$445,322
Joshua M Hare · University Of Miami School Of Medicine · R01 · FY2011 · HL

Targeting Mitochondrial Cyclophilin D in Vascular Oxidative Stress and Hypertension

$445,315
Sergey Dikalov · Vanderbilt University Medical Center · R01 · FY2019 · HL

Cell-Based Sensors and Drug-Like Moldulators Targeting ppGalNAc-Transferases

$445,273
Adam D Linstedt · Carnegie-Mellon University · U01 · FY2018 · CA

Cell-Based Sensors and Drug-Like Moldulators Targeting ppGalNAc-Transferases

$445,226
Adam D Linstedt · Carnegie-Mellon University · U01 · FY2019 · CA

Role of myostatin in cardiac hypertrophy and failure

$445,193
Massachusetts General Hospital · R01 · FY2004 · HL

Novel regulators of macrophage function to repair sterile inflammation-induced heart injury

$445,191
Guochang Fan · University Of Cincinnati · R35 · FY2025 · GM

Structure-Aided Design of CYP51 Inhibitors for Treatment of Parasitic Infections

$445,180
Larissa M. Podust · University Of California, San Diego · R01 · FY2015 · AI

Mitochondrial R-loop in sepsis-induced cardiomyopathy

$445,156
Wei Huang · University Of Cincinnati · R01 · FY2023 · HL

Pulmonary hypertension: Genetic, Microbiome and Environmental Determinants

$445,136
Alison Morris · University Of Pittsburgh At Pittsburgh · P01 · FY2018 · HL

Reprogramming Non-myocytes to Cardiomyocytes in vivo

$445,062
Richard T Lee · Harvard University · R01 · FY2016 · HL

Novel Posttranslational Modifications in Adipose Biology

$445,060
Weiqin Chen · Augusta University · R01 · FY2024 · DK

Novel Posttranslational Modifications in Adipose Biology

$445,060
Weiqin Chen · Augusta University · R01 · FY2025 · DK

Mechanisms of organ dysfunction and recovery in the Acetaminophen and Ascorbate Trial in Sepsis

$445,056
Lorraine B Ware · Vanderbilt University Medical Center · R01 · FY2022 · HL

Small blood pumps for small patients

$445,050
Trevor Arnoult Snyder · Vadovations, Inc. · R44 · FY2014 · HL

Mechanisms of GalTKO Lung Xenograft Injury

$445,037
Richard N Pierson · University Of Maryland Baltimore · U01 · FY2007 · AI

Emergent role of allostery on function of GPCRs and Trimeric G proteins

$445,000
Nagarajan Vaidehi · Beckman Research Institute/City Of Hope · R35 · FY2025 · GM

Role of ROCK isoform-mediated actin cytoskeleton modification in the pathogenesis of heart disease

$444,960
Lei Wei · Indiana University Indianapolis · R01 · FY2023 · HL

Mechanisms of Islet1 Action in Heart Development

$444,937
Sylvia M Evans · University Of California, San Diego · R01 · FY2009 · HL

Tissue and organ specific human B cell immunity

$444,936
Frances E. Lund · University Of Alabama At Birmingham · U19 · FY2021 · AI